Humana Inc. (BIT:1HUM)
Italy · Delayed Price · Currency is EUR | Market Cap | 44.10B +62.7% |
| Revenue (ttm) | 127.51B +18.3% |
| Net Income | 1.12B -18.8% |
| EPS | 9.27 -18.8% |
| Shares Out | n/a |
| PE Ratio | 39.39 |
| Forward PE | 31.29 |
| Dividend | 2.31 (0.68%) |
| Ex-Dividend Date | Oct 29, 2026 |
| Volume | n/a |
| Open | 338.00 |
| Previous Close | 338.00 |
| Day's Range | 338.00 - 338.00 |
| 52-Week Range | 133.25 - 364.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 6, 2026 |
About Humana
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and... [Read more]
Financial Performance
In 2025, Humana's revenue was $129.66 billion, an increase of 10.11% compared to the previous year's $117.76 billion. Earnings were $1.19 billion, a decrease of -1.57%.
Financial numbers in USD Financial StatementsNews
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
Humana price target raised to $495 from $468 at Mizuho
Mizuho raised the firm’s price target on Humana (HUM) to $495 from $468 and keeps an Outperform rating on the shares. The firm cites the company “receiving its strong Star…
Humana announces new joint venture with BlackRock
Humana (HUM) announced it has entered into a new joint venture agreement with funds and accounts managed by HPS Investment Partners, a part of BlackRock (BLK), to manage and operate…
Humana Announces New Strategic Joint Venture with BlackRock to Manage CenterWell Senior Primary Care Clinics
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced it has entered into a new joint venture agreement with funds and accounts managed by HPS Investment Partners, a part of BlackR...
Humana Inc. to Release Third Quarter 2026 Results on November 6, 2026
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release its financial results for the third quarter 2026 (3Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eas...
Humana price target raised to $525 from $475 at Oppenheimer
Oppenheimer raised the firm’s price target on Humana (HUM) to $525 from $475 and keeps an Outperform rating on the shares. Following last week’s favorable Star Ratings release, the firm…
Humana price target raised to $495 from $405 at UBS
UBS raised the firm’s price target on Humana (HUM) to $495 from $405 and keeps a Neutral rating on the shares.
Humana price target raised to $475 from $415 at Truist
Truist analyst David MacDonald raised the firm’s price target on Humana (HUM) to $475 from $415 and keeps a Hold rating on the shares as part of broader research now…
Humana upgraded to Outperform from Market Perform at Raymond James
Raymond James upgraded Humana (HUM) to Outperform from Market Perform with a $520 price target Humana’s increase in 4-star-plus Medicare Advantage membership to 95% for 2027 from 41% in 2026…
Humana Stock (HUM) Soars on Improved Star Ratings, Baird Upgrades to ‘Buy’
Humana ($HUM) stock was up about 12% at the time of writing on Friday after the federal government’s latest data on the health insurer’s Medicare Advantage (MA) plans showed improved…
Friday's First Moves: CRWD & ZS Pirce Target Hikes, HUM Upgrade
Baird is now a bull in Humana (HUM) over greater confidence in the company's 2028 EPS goal. Diane King Hall explains why the note is significant for the rising healthcare company.
Humana Stock Jumps on Raised Medicare Advantage Ratings
Humana shares are soaring after the health insurer said it received improved star ratings for a number of its Medicare Advantage plans.
Humana price target raised to $475 from $405 at Oppenheimer
Oppenheimer raised the firm’s price target on Humana (HUM) to $475 from $405 and keeps an Outperform rating on the shares. Humana was the “biggest winner” from the Centers for…
Humana Says 95% of Medicare Advantage Members in 4-Star Plans for 2027
Humana said 95% of its Medicare Advantage members are enrolled in plans rated at least four stars for 2027, an improvement that could make more of its membership eligible for quality-related bonus pay...
Humana surges after emerging as top beneficiary of 2027 Medicare star ratings
Humana's shares rose 15% in premarket trading on Friday after analysts said the health insurer is the biggest beneficiary of the new star ratings for 2027 Medicare Advantage plans.
SpaceX, Verizon, Delta, Humana, and More Stocks That Explain Today's Market
SpaceX stock is rising, while AT&T, Verizon, and T-Mobile shares are falling as investors fret Elon Musk's aerospace company will muscle into telecom.
Humana up 15% to $444.50 after reporting improved Star Ratings for 2027
06:17 EDT Humana (HUM) up 15% to $444.50 after reporting improved Star Ratings for 2027
Humana announces improved Star Ratings for 2027
Humana (HUM) announced improved Star Ratings for 2027, highlighted by 95% of its Medicare Advantage members being enrolled in plans rated 4.0 stars or above by the Centers for Medicare…
Humana Announces Improved CMS Star Ratings with 95 Percent of Medicare Advantage Members in 4-Star or Above Plans for 2027
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM), a leading consumer healthcare company focused on helping people achieve their best health, today announced improved Star Ratings for 2027, hi...
Humana Faces Medicare ‘Stars' Rating. The Result Will Test the Stock.
Improving Medicare Advantage ratings isn't easy. Stars are based on 40-some criteria that encompass patient experience surveys and a range of care metrics.
BlueWind Medical Announces Humana Coverage of Revi® for Urgency Urinary Incontinence, Expanding Access to Millions of Patients
SALT LAKE CITY--(BUSINESS WIRE)--BlueWind Medical, a leader in Implantable Tibial Neuromodulation (ITNM) and developer of the Revi® System, a patient-centric solution for urgency urinary incontinence ...
Humana Generates Nearly $20 Billion in Economic Impact Across Kentucky, New Report Finds
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) and the University of Louisville today announced the publication of a new economic impact report examining Humana's contributions across the s...